Aura Biosciences (AURA) Other Non-Current Liabilities (2020 - 2022)

Aura Biosciences' Other Non-Current Liabilities history runs 3 years deep, the most recent figure standing at $67000.0 for Q2 2022.

• Quarterly Other Non-Current Liabilities changed N/A year-over-year to $67000.0 in Q2 2022, while the trailing twelve-month figure through Jun 2022 was $67000.0 (changed N/A YoY) and the FY2021 annual result came in at $83000.0, up 15.28% from the prior year.
• Other Non-Current Liabilities was $67000.0 for Q2 2022 at Aura Biosciences, down from $127000.0 in the prior quarter.
• Across five years, Other Non-Current Liabilities topped out at $127000.0 in Q1 2022 and bottomed at $67000.0 in Q2 2022.
• A 3-year average of $84000.0 and a median of $72000.0 in 2020 frame the typical range for Other Non-Current Liabilities.
• Peak annual rise in Other Non-Current Liabilities reached 15.28% in 2021, while the deepest fall reached 15.28% in 2021.
• Aura Biosciences' Other Non-Current Liabilities stood at $72000.0 in 2020, then rose by 15.28% to $83000.0 in 2021, then dropped by 19.28% to $67000.0 in 2022.
• Business Quant data shows AURA's Other Non-Current Liabilities at $67000.0 in Q2 2022, $127000.0 in Q1 2022, and $83000.0 in Q4 2021.